Dallas,Texas, April 16, 2019 (GLOBE NEWSWIRE) -- The global precision medicine market size is projected to be valued USD 119.90 billion by 2025. Advancement in genomic and proteomic sequencing with reduced costs, is bringing in the so-called “genomic revolution.” By identifying the optimal point of intervention for treatment, healthcare providers massively improve the quality of care. Additionally, these technologies offer optimized cost by effectively timing treatment intervention and eliminating the need for insufficient or excessive treatment regimens.
Request a PDF sample of the global Precision Medicine market research report @ https://adroitmarketresearch.com/contacts/request-sample/831
Next generation sequencing has shifted the paradigm of genomics by accomplishing entire genome sequencing in a matter of hours. The enhanced speed and ease of DNA sequencing has drastically reduced the cost. The cost of deciphering the entire human genome has dropped by an order of magnitude from USD 10,000 in 2011 to about USD 1,000 today. As genome sequencing costs are declining rapidly healthcare providers and patients are likely to be more inclined to seek treatments that are targeted to a particular illness.
Cost is a major issue for precision medicines. Precision medicines may overburden many healthcare systems which are currently under significant financial constraints. It is a major factor hindering the patient’s access to treatment. The new targeted drugs that are launched in the market, are so highly priced that the patients can hardly afford them unless the cost is fully covered by the payers.
The “Global Precision Medicine Market Size 2017 by Application (Oncology, Central Nervous System, Cardiology, Infectious disease and Others), By Region (US, Canada, Germany, UK, Italy, France, China, India, Japan, South Korea and Rest of World ) and Forecast 2018 to 2025” study provides an elaborative view of historic, present and forecasted market estimates.
Geographically, Asia Pacific led the precision medicine market share in the global market in 2017, growing with a CAGR of 14.38% from 2018 to 2025. Globally, 40 countries have their individual versions of precision medicine ingenuities. United States and China being one of them. China, is spending $43 for every $1 the United States is spending on its precision medicine initiatives. The Beijing Genome Institute has the world's largest sequencer and repository of genetic material. Additionally, developments in computational power and artificial intelligence are also in progress to discover new drugs, treatment and delivery methods. Wuxi Nextcode and Huawei are collaboratively developing cloud computing infrastructure to store and compute enormous amounts of data for precision medicines.
Furthermore, the Korean government is strategizing framework for implementation of precision medicine into clinical practice. The Korean Ministry of Food and Drug Safety, conducted a survey in 2012-2013, in order to explore the public awareness and attitude towards precision medicine. Results of the survey demonstrated low levels of public awareness regarding precision medicine, however, family income showed a positive correlation with precision medicine knowledge, thus reducing potential health disparities will increase the access to precision medicine.
Direct purchase the Single user copy of the research study @ https://adroitmarketresearch.com/researchreport/purchase/831 . or Are you looking for a discount on purchasing the report? If yes then, contact us @ https://adroitmarketresearch.com/contacts/discount/831
Some of the leading players operating in the market include Novartis International AG, F. Hoffmann-La Roche AG, AstraZeneca plc, Eli Lilly and Company, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Merck & Co. and others.
Major points from Table of Contents:
Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. Market Overview, By Application
Chapter 5. Market Overview, By Region
Chapter 6. Company Profiles
Continued…
Grasp advance knowledge on Precision Medicine Industry through in-depth Blogs, White Paper & Infographics:
Access the White Paper “Precision Medicine And The Future Of Health Technology” @ https://adroitmarketresearch.com/white-paper/precision-medicine-and-the-future-of-health-technology
Read the in depth blog titled “How Does Precision Medicine Benefit An Individuals’ Health?” @ https://adroitmarketresearch.com/blogs/how-does-precision-medicine-benefit-an-individuals-health
Browse more related reports:
Global Orphan Drugs Market 2018-2025:
North America dominates the global orphan drugs market backed by its favorable government regulations and highly developed healthcare infrastructure. In North America, the U.S.A. accounts the largest market share due to rising awareness and economic incentives leading to higher growth of orphan drugs market. Further, higher investments to diagnose and treat the rare disease also helps the growth of orphan drug market.
Browse and Pre-Book the report with 10% Discount @ https://www.adroitmarketresearch.com/industry-reports/orphan-drugs-market
Global Regenerative Medicine Market Size 2017-2023:
Several government organizations and private institutions are investing in the regenerative medicine industry, for research and development. New development is undertaken as per the rules and regulations standardized by organizations like Food and Drug Administration (FDA) in the USA, the European Medicines Agency (EMA) in Europe and other regional authorities. Browse and Pre-Book the report with 10% Discount @ https://www.adroitmarketresearch.com/industry-reports/regenerative-medicine-market
Global Nuclear Medicine Market Size and Forecast, 2018-2025:
If we talk about the application, the global nuclear medicine market has segmented into diagnostics and therapeutics. The diagnostics segment includes oncology, cardiology, neurology, thyroid, lymphoma, and other. The therapeutics segment has further divided into bone metastasis, lymphoma, endocrine tumor, thyroid, and others.
Browse and Pre-Book the report with 10% Discount @ https://www.adroitmarketresearch.com/industry-reports/nuclear-medicine-market
Global Biologics Market Size and Forecast, 2018-2025:
Global biologics market is segmented on the basis of application, source, type and region. Based on application, biologics market is divided into cancer, anemia, diabetes and many more. By source, market is divided into animal, human and microorganism. Based on type, biologics market is splited into blood products, gene therapy, vaccines, proteins, monoclonal antibodies and much more.
Browse and Pre-Book the report with 10% Discount @ https://www.adroitmarketresearch.com/industry-reports/biologics-market
Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html
About Us:
Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us:
Ryan Johnson
Account Manager - Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: sales@adroitmarketresearch.com
Phone No.: +1 (214) 884-6068
Connect with us: Facebook | Twitter | LinkedIn